Market Research Logo

Biologic and Medical Imaging Reagents: Global Markets

Biologic and Medical Imaging Reagents: Global Markets

Report Highlights
The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022.

Report Includes
32 data tables and 76 additional tables
An overview of the global markets for biologic and medical imaging reagents
Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
A comprehensive analysis of imaging techniques as an important tool in medical diagnostic procedures
Coverage of current and future strategies within the medical imaging technology market
A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods
A detailed analysis of the industry structure
Profiles of major players in the industry

Report Scope
Topics covered in this report include:
Fluorescent dyes and probes.
Fluorescent proteins.
Nanoparticles, including quantum dots.
Supermolecules.
Imaging radiopharmaceuticals.
Contrast reagents for X-ray/CT, MRI and ultrasound.

Topics not covered in this report include:
Nanotechnology.
Drug delivery.
Coatings.
Supramolecular chemistry.
Imaging instruments and software.

The scope of the study includes the biological imaging reagents that are already commercialized or likely to be commercialized within the next five years. Fluorescent probes and dyes; imaging nanomaterials (including quantum dots and other nanoparticles); fluorescent proteins; contrast reagents for MRI, X-ray and ultrasound; and imaging radiopharmaceuticals are studied. Both the in vivo and in vitro market segments are included. Each technology is analyzed to determine its market status, impact on future market segments and forecast growth from 2017 through 2022. Technology status and market driving forces are also discussed.

BCC Research examines imaging reagent producers and the industry structure in specialized segments of the industry. We also review industry alliances and acquisitions, and the use of biological imaging reagents in key diagnostics and research and development (R&D) tools platforms, including microarrays, lab-on-a-chip devices, DNA sequencing, PCR and cellular analysis. The markets for novel biological imaging reagent applications, including targeted multifunctional and hybrid therapeutic reagents, are analyzed, and the main companies in these fields are highlighted.


Chapter 1: Introduction
Study Goals and Objectives
Reasons for Doing the Study
Contribution of the Study and for Whom
Scope of Report
Methodology
Information Sources
Analyst's Credentials
Related BCC Reports
Chapter 2: Executive Summary
Chapter 3: Overview
Introduction
Market Potential
Industry Growth Driving Forces
Industry Growth Drivers
Demand for Theranostics Regime
Image-Based Invasive and Noninvasive Procedures
Increasing Prevalence of Chronic Diseases and Rising Investments
Drug Discovery and Other R&D Activities
Development of Multifunctional Reagent Capabilities
Replacement of Toxic, Hazardous Detection Reagents with Safer Reagents
Biological Imaging Reagents Industry
Chapter 4: Biological Imaging Technologies
Imaging Reagent Types
In Vivo Imaging Modalities
Trends in In Vivo Imaging
Molecular Imaging
In Vitro Imaging/Detection
Biological Imaging Reagents Technologies
Nanoparticles
Fluorescent Dyes and Probes
Supermolecules
Quantum Dots
Radiopharmaceutical Imaging Reagents
Contrast Imaging Reagents
Emerging Classes of Imaging Reagents
Components of Advanced Imaging Reagent Technology
Advanced Imaging Reagent Functions
Comparison of Imaging Reagent Technology Platforms
Chapter 5: Biological Imaging Reagents Applications
Overview
Research and Development
Drug Discovery and Development
Diagnostics
Chapter 6: Biological Imaging Reagents Industry Structure
Overview
Research and Development
Drug Discovery and Development
Influence of Imaging Technology on Drug Development
Attrition Rate of Lead Drug Compounds
Fluorescent Protein Applications in Drug Discovery
In Vivo Small Animal Imaging Applications
Diagnostics
Introduction
Diagnostic Applications of Imaging Reagents
Molecular Imaging
Chapter 7: Competitive Landscape
Innovation Within the Imaging Reagent Industry
Strategic Alliances
Industry Acquisitions
Medical Imaging Instrument Sector
Fluorescent Dyes and Probes Industry Structure
Quantum Dots Industry
Contrast Reagents Industry
Radiopharmaceuticals Industry
Radioactive Isotopes Supply
Small Animal In Vivo Imaging Industry
Cardiac Imaging Industry
Radiopharmaceuticals for the Screening Market Segment Include Ablavar and Vasopet
Prostate Cancer Imaging Industry
Alzheimer's Disease PET Imaging Industry
Chapter 8: Biological Imaging Reagents Markets
Growth Driving Forces
Market Overview
Chapter 9: Patent Status
Chapter 10: Company Profiles
About BCC Research
About BCC Research
BCC Membership
BCC Custom Research
List of Tables
Summary Table Global Biological Imaging Reagents Market, by Modality, Through 2022 ($ Millions)
Table 1 Global Biological Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
Table 2 Global Biological Imaging Reagents Market, by End User, Through 2022 ($ Millions)
Table 3 Biological Imaging Reagents Growth Driving Forces
Table 4 Current and Future Invasive and Noninvasive Imaging Technologies
Table 5 Other Driving Factors
Table 6 Life Cycle Stage of Biological Imaging Reagents
Table 7 Key Biological Imaging Reagents Companies
Table 8 Key Biological Imaging Reagent Types
Table 9 In Vivo Imaging Modalities
Table 10 Comparison of In Vivo Imaging Modalities
Table 11 Key Technology Drivers for In Vivo Imaging Reagents
Table 12 Applications of In Vitro Biological Imaging
Table 13 Nanoparticles in Imaging Applications
Table 14 Fluorescent Dyes and Probes
Table 15 General Advantages of Fluorescence Labels
Table 16 Fluorescent Dye Performance Criteria
Table 17 Types of Fluorescent Proteins
Table 18 Photoactivable and Photoconvertible Fluorescent Protein Types
Table 19 Emerging Applications of Fluorescent Proteins
Table 20 Fluorescent Proteins Versus Dyes
Table 21 Technology Challenges for Fluorescent Proteins
Table 22 Classification of Imaging Supermolecules
Table 23 Comparison of Quantum Dots, Fluorescent Dyes and Fluorescent Proteins
Table 24 Biological Imaging Applications of Quantum Dots
Table 25 Microbubble Ultrasound Imaging Agents
Table 26 Emerging Advanced Biological Imaging Reagent Functions
Table 27 Life Cycle of Biological Imaging Reagent Technologies
Table 28 Technology Status of Biological Imaging Reagent Platforms
Table 29 Technology Challenges for In Vivo Imaging Reagents
Table 30 Biological Imaging Reagents Applications
Table 31 Significance of Biological Imaging Reagents to Life Sciences and Medical Industries
Table 32 Use of Biological Imaging Reagents, by Market Segment
Table 33 Applications Within Market Segments
Table 34 R&D Tools Imaging Reagents
Table 35 Emerging Applications for Biological Imaging Reagents in R&D Tools
Table 36 Imaging Applications in Drug Discovery and Development
Table 37 Comparison of Small Animal Imaging Modalities
Table 38 Outstanding Market Needs for Small Animal Imaging
Table 39 Diagnostics Imaging Reagents Applications
Table 40 Diagnostic Applications of Selected Imaging Reagents
Table 41 Clinical Applications of In Vivo Molecular Imaging
Table 42 Biological Imaging Reagents Applications
Table 43 Significance of Biological Imaging Reagents to the Life Sciences and Medical Industries
Table 44 Use of Biological Imaging Reagents, by Market Segment
Table 45 Applications Within Market Segments
Table 46 R&D Tools Imaging Reagents
Table 47 Emerging Applications for Biological Imaging Reagents in R&D Tools
Table 48 Imaging Applications in Drug Discovery and Development
Table 49 Comparison of Small Animal Imaging Modalities
Table 50 Outstanding Market Needs for Small Animal Imaging
Table 51 Diagnostics Imaging Reagents Applications
Table 52 Diagnostic Applications of Selected Imaging Reagents
Table 53 Clinical Applications for In Vivo Molecular Imaging
Table 54 Recent FDA Approvals in the Biological Imaging Reagent Industry
Table 55 Biological Imaging Reagent Strategic Alliances, 2010–2017*
Table 56 Biological Imaging Reagents Industry Acquisitions, 2010–2017*
Table 57 Competitive Focus of Major Medical Imaging Companies
Table 58 Fluorescent Imaging Reagents Competitors
Table 59 Quantum Dot Competitors
Table 60 Contrast Agents Key Competitors
Table 61 Global Imaging Radiopharmaceuticals Companies
Table 62 Radiopharmaceuticals Biotechnology Companies
Table 63 Small Animals In Vivo Functional Imaging Reagent Competitors
Table 64 Cardiac Imaging Reagent Competitive Space
Table 65 Prostate Cancer Imaging Agent Competition
Table 66 Alzheimer’s Disease PET Imaging Agent Competitive Space
Table 67 Biological Imaging Reagents Growth Driving Forces
Table 68 Global Biological Imaging Reagents Market, by Application, Through 2022 ($ Millions)
Table 69 Global Biological Imaging Reagents Market, by Technology, Through 2022 ($ Million)
Table 70 Global Biological Imaging Reagents Market, by End Use, Through 2022 ($ Millions)
Table 71 Global Biological Imaging Reagents Market, by End User, Through 2022 ($ Millions)
Table 72 Global Biological Reagents Market, by Modality, Through 2022 ($ Millions)
Table 73 Global Contrast Reagents Market, by Modality, Through 2022 ($ Millions)
Table 74 Global MRI Contrast Reagents Market, by Type, Through 2022 ($ Millions)
Table 75 Global Gd-Chelate MRI Contrast Reagents Market, by Product, Through 2022 ($ Millions)
Table 76 Key Brands of Gadolinium‐Based Contrast Reagents Worldwide
Table 77 Global Non-Gd Chelate MRI Contrast Reagents Market, Through 2022 ($ Millions)
Table 78 Global MRI Contrast Reagents Market, by Procedure, Through 2022 ($ Millions)
Table 79 Global X-Ray/CT Reagents Market, by Type, Through 2022 ($ Millions)
Table 80 Global X-Ray/CT Reagents Market, by Indication, Through 2022 ($ Millions)
Table 81 Global Radiopharmaceuticals Imaging Reagents Market, by Scanner Type, Through 2022 ($ Millions)
Table 82 Global Radiopharmaceuticals Imaging Reagents Market, by Isotope, Through 2022 ($ Millions)
Table 83 Global Radiopharmaceuticals Imaging Reagents Market, by Indication, Through 2022 ($ Millions)
Table 84 Global Radiopharmaceuticals Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
Table 85 Global SPECT Imaging Reagents Market, by Isotope, Through 2022 ($ Millions)
Table 86 Half-Life of Common PET and SPECT Isotopes
Table 87 Sentinel Node Detection Radiopharmaceuticals Producers
Table 88 Global SPECT Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
Table 89 Global PET Imaging Reagents Market, by Isotope, Through 2022 ($ Millions)
Table 90 Global PET Imaging Reagents Market, by Indication, Through 2022 ($ Millions)
Table 91 Global PET Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
Table 92 Global Optical Fluorescent Imaging Reagents Market, by Application, Through 2022 ($ Millions)
Table 93 Global In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
Table 94 Global Genomics In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
Table 95 Global Proteomics In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
Table 96 Global Cellular Analysis In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
Table 97 Global Optical Fluorescent Imaging Reagents Market, by End Use, Through 2022 ($ Millions) 169
Table 98 Global In Vitro Optical Imaging Reagents Market, by Type, Through 2022 ($ Millions)
Table 99 Global Biological Imaging Reagents Market, by Region, Through 2022 ($ Millions)
Table 100 U.S. Patents on Imaging Reagents Through 2017
Table 101 European Patents on Imaging Reagents, Through 2017
Table 102 Japanese Patents on Imaging Reagents, Through 2017
Table 103 Affibody Alliances
Table 104 FluoroPharma PET Imaging Reagent Pipeline
Table 105 Kereos Imaging Reagents Pipeline
Table 106 Molecular Insight Imaging Reagents Pipeline
Table 107 Lymph Node Status
List of Figures
Summary Figure Global Biological Imaging Reagents Market, by Modality, 2016–2022 ($ Millions)
Figure 1 Factors Impacting the Growth of the Biological Imaging Reagents Market, 2016 and 2023
Figure 2 Current and Forecast Venture Capitalist Investment in the U.S. and European Medical Device Sectors, 2014–2018 ($ Billions)
Figure 3 Forecast Investment in Drug Development and Research Spending, by Pharmaceutical Company, 2014–2020 ($ Billions)
Figure 4 Quantum Dot Spectra (Intensity) (Arb units, nm)
Figure 5 Fluorescent Dye Spectra (Arb units, nm)
Figure 6 Three Components of Advanced Imaging Reagent Technology
Figure 7 Attrition Rate of Drug Candidates During Drug Development
Figure 8 Global Geriatric Population (65+), 2015 and 2020 (Millions)
Figure 9 Global R&D Spending in Nanotechnology, 2013–2015 ($ Billions)
Figure 10 Worldwide Prevalence of Alzheimer’s, 2015, 2030 and 2050 (Millions)
Figure 11 Number of New Cancer Cases Found in North America by Country, 2016
Figure 12 Number of People Impacted by Disability Adjusted Life Year Due to Alzheimer’s Disease, 2005-2030 (Thousands)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report